View Transactions

Laidlaw Capital Markets

Laidlaw Capital Markets offers our clients alternatives to highly structured financings that often paralyze a company’s capital structure. WE ARE BRAND COGNIZANT and strive to perform outreach to a broad base of Healthcare and Technology fundamental investors. Our team has extensive experience in executing transactions for both debt and equity in the private and public markets.

Our objective is to perform in a way where we cultivate long term relationships with exciting and growth oriented companies. We “roll up our sleeves” and help our clients add top tier shareholders, increase their liquidity profile and get their story out in a meaningful and thoughtful way. As you will see in our Case Studies, we are able to leverage our diverse institutional and retail network of sophisticated investors to deliver superior results across a variety of deal structures.

The Laidlaw Capital Markets Team has collaborated with organizations in developing strategies and goals on an individual company basis as well as assisting them in navigating the path to achieve their desired results. We have a demonstrated track record of providing the best funding available for companies that have work to do prior to moving upstream. As your company continues to grow and mature, the Laidlaw Capital Markets Team stays with you and will make introductions to Healthcare Centric Funds and Investment Banks. We believe you will the find the Laidlaw Capital Markets Brand to be true partner in your growth.

We would happy to provide you with Management References at many of the companies we have assisted.

  • Initial Public Offering (IPO)
  • Follow-On Offering
  • Confidentially Marketed Public Offering (CMPO)
  • Registered Direct (RD)
  • PIPE Transaction
  • Private Placement
  • Block trade

All of our offerings

2018-05-04T15:55:48-04:00

Aeolus
Pharmaceuticals

PIPE Transaction
Common Stock
& Warrants

$6,750,000

Exclusive Placement Agent
December 2015

2018-05-04T15:54:44-04:00


Cerecor, Inc.

Initial Public Offering
Common Stock
& Warrants

$26,000,000

Lead Manager
October 2015

2018-05-04T15:59:54-04:00

Sevion
Therapeutics

PIPE Transaction
Common Stocks
& Warrants

$7,325,217

Exclusive Placement Agent
July 2015

2018-05-04T16:00:52-04:00

Viking
Therapeutics

Initial Public Offering
Common Stock
 

$27,600,000

Sole Book-Runner
May 2015

2018-05-04T16:03:10-04:00


ADMA Biologics

Follow-On Offering
Common Stock
 

$9,800,000

Co-Manager
March 2015

2018-05-04T16:03:50-04:00

Medovex
Corporation

Initial Public Offering
Common Stock
& Warrants

$9,200,000

Sole Book-Runner
December 2014

2018-05-04T16:04:24-04:00

Cel-Sci
Corporation

Follow-On Offering
Common Stock
& Warrants

$7,000,000

Sole Book-Runner
October 2014

2018-05-04T16:05:31-04:00

Cel-Sci
Corporation

Follow-On Offering
Common Stock
& Warrants

$10,000,000

Joint Book-Runner
April 2014

2018-05-04T16:11:19-04:00

Cel-Sci
Corporation

Follow-On offering
Common Stock & Warrants
 

$3,000,000

Sole Book-runner
December 2013

2018-05-04T16:11:34-04:00


ADMA Biologics

Initial Public Offering
Common Stock
 

$28,347,500

Co-Manager
October 2013

2018-05-04T16:11:55-04:00

Cel-Sci
Corporation

Follow-On Offering
Common Stock
& Warrants

$17,826,087

Co-Manager
October 2013

2018-05-04T16:12:06-04:00

Relmada
Therapeutics

Convertible
Preferred Stock
& Warrants

$8,000,000

Placement Agent
September 2013

2018-05-04T16:12:39-04:00

Relmada
Therapeutics

Convertible Bridge
Notes & Warrants
 

$750,000

Placement Agent
September 2013

2018-05-04T16:12:58-04:00


Alliqua

Common Stock &
Warrants
 

$3,000,000

Co-Manager
July 2013

2018-05-04T16:13:03-04:00

BioSig
Technologies

Convertible
Preferred Stock
 

$2,800,000

Exclusive Placement Agent
July 2013